Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Two finasteride tablet formulations are bioequivalent.

The document informed plastic surgeons about upcoming educational events worldwide.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Minoxidil and Propecia are the only FDA-approved hair growth drugs, but concerns about side effects lead people to explore herbal alternatives.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Herbal supplements like Berberine, Cinnamon, and Fenugreek may be affordable alternatives for managing PCOS.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

A reliable method was developed to measure finasteride in hair products.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Sunlight exposure increases drug toxicity; amber glass best for protection.

PCOS is a hormonal disorder in women with no cure, managed by medication and lifestyle changes.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Patient care should come before profit in medicine.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.